Nu-Med Plus (NUMD) Shares Outstanding (2011 - 2025)
Nu-Med Plus (NUMD) Shares Outstanding (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 385.10 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | 456.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 867.00 Mn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 951.57 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 83.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.55 Mn |
| Sep 30, 2025 | 83.55 Mn |
| Jun 30, 2025 | 83.55 Mn |
| Mar 31, 2025 | 83.55 Mn |
| Dec 31, 2024 | 83.55 Mn |
| Sep 30, 2024 | 81.35 Mn |
| Jun 30, 2024 | 81.35 Mn |
| Mar 31, 2024 | 83.55 Mn |
| Dec 31, 2023 | 81.67 Mn |
| Sep 30, 2023 | 81.35 Mn |
| Jun 30, 2023 | 81.35 Mn |
| Mar 31, 2023 | 81.35 Mn |
| Dec 31, 2022 | 79.95 Mn |
| Sep 30, 2022 | 79.74 Mn |
| Jun 30, 2022 | 79.35 Mn |
| Mar 31, 2022 | 79.35 Mn |
| Dec 31, 2021 | 73.37 Mn |
| Sep 30, 2021 | 79.35 Mn |
| Jun 30, 2021 | 79.35 Mn |
| Mar 31, 2021 | 79.28 Mn |